Norwood gets European patent for skin surface laser
Tuesday, 18 February, 2003
The European Patent Office has granted Norwood Abbey (ASX: NAL) a patent for its laser perforator technology, covering a device and method for the perforation of the skin for draining blood or administering pharmaceuticals.
The patent has been granted in Belgium, France, Germany, the UK, Italy, the Netherlands, Spain and Sweden and will strengthen Norwood's intellectual property position for its Laser Assisted Delivery (LAD) technology. The company now has 13 patents around its LAD devices and at least a further 10 applications pending, a company spokeswomen said. Norwood won its first approval of a LAD device, for delivering local anaesthetic, in the US in January.
At the time of writing, the company's share price was 55c.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
